Biotech remains a red-hot area for startup founders and investors, with next-generation gene therapies, precision medicine, and the use of AI and ML to accelerate the discovery and development of new drugs, alongside entirely new delivery methods.
Louis Lehot, Partner and Business Lawyer at Foley & Lardner LLP, joined a livestream panel discussion on Biotech trends in 2023, hosted by Foley & Lardner and 4thly. The panel of experts discussed what the future looks like and how investors and founders should navigate the opportunities in this sector.
Find the video recording of the webinar here.
Discover more about Louis Lehot and explore additional professional insights on his website https://louislehot.com
Explore Related Content:
Louis Lehot Discusses Biotech Trends 2023